diseas
accord
global
burden
diseas
gbd
current
portfolio
cs
review
diseas
group
whether
top
whether
previou
work
identifi
low
represent
within
cs
portfolio
final
list
group
titl
review
cs
clinic
editor
respect
current
titl
potenti
number
review
could
support
rank
combin
gener
overal
prioriti
list
new
titl
advertis
competit
applic
suitabl
qualifi
resourc
author
team
prioriti
titl
current
progress
support
extra
editori
resourc
author
team
make
adequ
progress
extra
support
offer
cs
titl
readvertis
review
new
qualifi
resourc
team
prioriti
titl
cs
aim
produc
highqual
systemat
review
within
month
titl
registr
go
forward
cs
continu
support
exist
portfolio
review
protocol
consid
author
suggest
new
review
titl
annual
basi
relat
editori
capac
cs
rank
relat
titl
recent
priorit
exercis
potenti
disadvantag
includ
limit
gbd
data
global
region
may
skew
titl
prioriti
cs
increas
focu
support
highprior
potenti
highimpact
systemat
review
titl
gener
formal
priorit
process
consist
cochran
collabor
strategi
aim
produc
time
highprior
review
evid
guid
health
decisionmak
cs
repeat
priorit
process
everi
year
ensur
portfolio
continu
includ
import
time
systemat
review
titl
methodolog
shift
product
cs
systemat
review
necessari
ensur
cochran
author
editori
resourc
continu
util
area
evid
synthesi
need
routin
updat
exist
review
redund
review
incongru
methodolog
dilut
qualiti
relev
systemat
review
implement
priorit
system
allow
cochran
commit
resourc
highimpact
review
produc
time
manner
embrac
newer
methodolog
network
metaanalysi
allow
cochran
ensur
inhous
methodolog
expertis
use
fullest
extent
cs
longer
aim
maintain
uptod
portfolio
cover
skin
diseas
focu
rapid
deliveri
smaller
number
highprior
potenti
practicechang
review
use
cuttingedg
review
methodolog
cs
ensur
inform
gap
address
facilit
time
support
relev
clinic
guidelin
addit
support
inform
may
found
onlin
version
articl
publish
websit
file
full
author
affili
conflict
interest
statement
fund
sourc
cochran
skin
support
uk
nation
institut
health
research
conflict
interest
see
file
support
inform
doi
dear
editor
psoriasi
chronic
inflammatori
skin
diseas
affect
popul
worldwid
predomin
plaqu
psoriasispsoriasi
vulgari
pv
subtyp
result
interact
complex
genet
background
environment
factor
lead
dysregul
skin
immun
respons
limit
studi
identifi
streptococc
tonsillar
infect
trigger
guttat
psoriasi
pv
contribut
common
viral
pathogen
name
respiratori
virus
remain
unknown
although
suspect
gener
pustular
psoriasi
gpp
attack
pilot
studi
collect
consecut
case
psoriasi
flare
follow
respiratori
tract
infect
rti
patient
elig
present
psoriasi
flare
defin
worsen
compar
statu
prior
rti
base
bodi
surfac
area
bsa
andor
psoriasi
area
sever
index
pasi
score
ii
within
month
follow
upper
rti
onset
iii
present
rti
symptom
inclus
diseas
sever
bsa
pasi
treatment
receiv
beforeaft
flare
trigger
time
rti
flare
also
record
patient
nasopharyng
swab
test
multiplex
polymeras
chain
reaction
pcr
test
viral
pathogen
four
bacteria
chlamydophila
pneumonia
mycoplasma
pneumonia
legionella
pneumophila
bordetella
sp
respifind
pathofind
maastricht
netherland
bacteri
cultur
genet
studi
consist
dna
sequenc
code
sequenc
gene
sanger
method
februari
novemb
enrol
patient
includ
women
pv
gpp
baselin
median
age
year
consult
flare
rti
symptom
total
patient
receiv
baselin
system
treatment
psoriasi
convent
agent
phototherapi
n
biolog
agent
n
antitumour
necrosi
factora
n
antiinterleukin
il
n
n
median
delay
first
rti
symptom
psoriasi
flare
onset
day
eight
patient
show
chang
psoriasi
clinic
phenotyp
vs
baselin
guttat
pustular
respect
six
two
patient
pv
median
bsa
rang
pasi
rang
flare
vs
last
avail
assess
prior
rti
patient
selfassess
bsa
also
use
check
worsen
threshold
reach
pv
case
gpp
flare
led
admiss
includ
intens
care
unit
one
patient
ditra
defici
receptor
antagonist
nasopharyng
swab
test
posit
tabl
overal
patient
least
one
posit
multiplex
pcr
viral
test
rhinoviru
coronaviru
frequent
detect
pathogen
two
bacteri
swab
posit
one
staphylococcu
aureu
streptococcu
dysgalactia
trigger
record
case
patient
report
delay
ustekinumab
inject
psycholog
stress
respect
two
flare
associ
posit
viral
test
six
patient
gpp
pv
present
two
flare
studi
patient
report
histori
previou
acut
psoriasi
flare
follow
rti
includ
two
patient
gppditra
share
homozyg
c
sever
mutat
genet
abnorm
detect
patient
final
acut
flare
led
chang
antipsoriat
regimen
case
includ
new
onset
switch
convent
biolog
treatment
five
document
first
time
acut
psoriasi
flare
follow
establish
respiratori
viru
infect
without
evid
group
streptococcu
although
design
studi
allow
us
ascertain
causal
rti
acut
pv
gpp
flare
potenti
lifethreaten
latter
sever
argument
support
imput
short
delay
viral
infect
symptom
onset
psoriasi
flare
mean
day
ii
repetit
viral
rti
five
case
iii
psoriasi
phenotyp
chang
follow
infect
presenc
guttat
pustular
lesion
patient
pv
guttat
psoriasi
previous
relat
streptococc
pharyng
infect
epidemiolog
immunolog
studi
casecontrol
studi
suggest
recent
pharyng
infect
associ
seven
fold
increas
risk
guttat
psoriasi
although
without
identifi
infecti
agent
previous
show
product
pathogen
cytokineschemokin
enhanc
primari
keratinocyt
patient
ditra
stimul
polyinosinicpolycytidyl
acid
tolllik
receptor
agonist
mimick
rna
respiratori
virus
suggest
dysregul
innat
immun
respons
patient
sever
inflammatori
cytokin
downstream
includ
shown
pathogen
gpp
pv
present
result
pave
way
larger
epidemiolog
studi
assess
actual
impact
viral
trigger
psoriasi
cours
